MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2025 International Congress

    Depressive Symptomatology in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia. Descriptive Study of the ESDEPARK Scale.

    P. Andrea Gutiérrez-Lenis, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Maria Villegas-Trujillo, S. Ordoñez-Cure, M. Alejandra Vásquez-Martínez (Zaragoza, Spain)

    Objective: To evaluate the frequency of depression in a group of patients diagnosed with IPDWD, assessed by a new ESDEPARK scale that specifically measures depressive…
  • 2025 International Congress

    The Impact of Non-Motor Symptoms on Quality of Life in Early Parkinson’s Disease: A Prospective Study

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the prevalence and severity of non-motor symptoms (NMS) in early Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL).…
  • 2025 International Congress

    Quality of Life and Depression in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, J. Marmolejo-Florez (Cali, Colombia)

    Objective: To identify the impact of depression on QoL in a group of patients with IPDWD. Background: The Quality of Life (QoL) in patients with…
  • 2024 International Congress

    Pharmacokinetic Intersections in Geriatric Neuropharmacology: A Parkinson’s Disease Case Study with Concomitant Refractory Major Depressive Disorder

    D. Nolasco, L. Schmidt, B. Carr (Gainesville, USA)

    Objective: This investigation delineates the pharmacokinetic intricacies encountered in the therapeutic management of a geriatric patient with Parkinson’s Disease (PD) concomitantly suffering from refractory Major…
  • 2024 International Congress

    Loneliness Relates to Gait Over Other Features of Parkinsonism

    D. Gonzalez, R. Wilson, M. Tosin, C. Goetz (Chicago, USA)

    Objective: To assess the relationship between loneliness and facets of parkinsonism in community-based samples. Background: Loneliness increases the risk of mortality, dementia, depression, and motor…
  • 2024 International Congress

    Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

    K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)

    Objective: To evaluate cognitive decline in people living with PD (PwP), to determine to which degree different neuropsychiatric symptoms are risk factors for cognitive decline…
  • 2024 International Congress

    A Novel Peer Mentoring Support System for Persons with Parkinson’s Disease

    E. Lubas, TW. Liang, K. Stoveld, SK. Thurman (Philadelphia, USA)

    Objective: Research indicates that peer mentoring approaches can be effective in providing support as well as increasing the well-being of people with various disabilities or…
  • 2024 International Congress

    Neuropathological Synergy in Cauda Equina Syndrome, Parkinson’s Disease, And Depression: Breaking the Dysphoric Cycle

    R. Grace, L. Velez, R. Islam, B. Carr (Gainesville, USA)

    Objective: This study endeavors to understand the intricate pathophysiological interactions among concurrent manifestations of cauda equina syndrome, Parkinson’s Disease (PD), and depression, with the objective…
  • 2024 International Congress

    Incidence of Depression in the Caregivers of Parkinson’s Disease Patients

    S. Soleimani, M. Salari, F. Hojjati Pour (Tehran, Islamic Republic of Iran)

    Objective: To evaluate the impact of caring for individuals with Parkinson's disease on caregivers' social activities and mental health, and to assess depression and quality…
  • 2024 International Congress

    Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study

    C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, C. Cevallos-Velasco, M. Barreiro-Guillén, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Investigate gender-specific disparities in depressive symptoms among Hispanic Parkinson's disease (PD) patients using Center for Epidemiologic Studies Depression Scale (CES-D) scores. Background: PD not…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley